AdvertiseDonate
True Media Live · 685 Citadel Drive East, Colorado Springs, CO 80909
News · Kansas City

Vermont runner competes at 91 as new data shifts peanut allergy advice

Experts on Aging Untold discuss clinical trial access for older adults and explain why introducing peanut products early may lower allergy rates.

By Emmanuel Faure ·

Illustration for: Vermont runner competes at 91 as new data shifts peanut allergy advice
Illustration generated for this article, not a news photograph.

A 91-year-old track athlete in Vermont continues to compete in world-record events, while new data suggests that early exposure to peanut products reduces allergy rates in young children. These topics were featured on the October 30 episode of Aging Untold, a health program that addresses issues for older adults.

The episode began by examining how aging and illness affect physical intimacy. Experts on the show noted that couples often hesitate to discuss sexual health after a medical diagnosis. They emphasized that competence and consent are the primary factors to consider when determining if sexual activity is safe. Sam Cradduck, a gerontologist, stated that the first step in addressing changes in intimacy is identifying the underlying cause.

Dr. Rhea Rogers, a board-certified physician, addressed common misconceptions regarding sexuality in later life. She explained that many couples incorrectly treat intimacy and sexuality as the same thing. Rogers argued that these are distinct concepts. For physical conditions such as erectile dysfunction, she noted that medical professionals can often provide effective treatments.

The program also explored the role of older adults in clinical trials. Experts said that older participants are frequently underrepresented in these studies. However, clinical trials offer a proactive method to test new treatments. Rogers advised potential participants to first understand the specific question a trial aims to answer. She added that many people view trials as a last resort, but the main benefit is early access to medical innovations.

“You get great access to tomorrow’s medicines today, devices, therapies and other things that will not be available to everybody else for years,” Rogers said. Amy O’Rourke, an aging expert on the show, reminded listeners that participants should be aware they might receive a placebo during a study. The segment covered how to locate trials and which studies provide financial compensation to participants.

A separate segment on the show focused on peanut allergies in infants. New research indicates that introducing peanut products to babies between 4 and 6 months of age lowers the risk of developing an allergy. This finding contradicts earlier medical advice that suggested avoiding peanut products for young children. The new approach appears to have had a measurable impact on public health data.

A study released in October 2025 found that peanut allergy rates in children under 3 have dropped by roughly 43 percent over the last decade. This decline aligns with the shift in feeding recommendations for infants. The data supports the current medical guidance on early introduction of allergens to prevent sensitivity.

The episode concluded with a profile of Flo Meiler, a resident of Vermont who holds two world records in track and field. Meiler began competing at age 60 and remains active at 91. Her home is filled with medals from her athletic career. “I’m sad that I can’t jump like I used to, but I really enjoy it,” Meiler said about her continued participation in the sport.

Source: KCTV5

More News · Report a business · Got a Story?

Get True Media Live in your inboxBig-city news, all in one place. Free, a few times a week, unsubscribe any time.

Related stories

Get True Media Live in your inboxBig-city news, all in one place. Free, a few times a week, unsubscribe any time.